罗恩 |
R019181-5mg |
5mg |
现货 |
1202757-89-8 |
N-[3-[[5-氟-2-[[4-(2-甲氧基乙氧基)苯... N-[3-[[5-fluoro-2-[4-(2-meth... |
98% |
33.00
33.00
|
|
罗恩 |
R019181-10mg |
10mg |
现货 |
1202757-89-8 |
N-[3-[[5-氟-2-[[4-(2-甲氧基乙氧基)苯... N-[3-[[5-fluoro-2-[4-(2-meth... |
98% |
47.00
47.00
|
|
阿拉丁 |
A127694-5mg |
5mg |
现货 |
1202757-89-8 |
AVL-292 AVL-292 |
Moligand™, ≥98% |
425.90
425.90
|
|
阿拉丁 |
A127694-10mg |
10mg |
现货 |
1202757-89-8 |
AVL-292 AVL-292 |
Moligand™, ≥98% |
647.90
647.90
|
|
阿拉丁 |
A127694-50mg |
50mg |
现货 |
1202757-89-8 |
AVL-292 AVL-292 |
Moligand™, ≥98% |
2,490.90
2,490.90
|
|
阿拉丁 |
A127694-100mg |
100mg |
期货,请咨询 |
1202757-89-8 |
AVL-292 AVL-292 |
Moligand™, ≥98% |
4,119.90
4,119.90
|
|
阿拉丁 |
A420893-1ml |
1ml |
现货 |
1202757-89-8 |
AVL-292 AVL-292 |
Moligand™, 10mM in DMSO |
659.90
659.90
|
|
阿法埃莎 |
C46806-100MG |
100MG |
现货 |
1202757-89-8 |
斯比布鲁替尼,95% Spebrutinib, 95% |
|
4,346.00
4,346.00
|
|
毕得 |
BD328411-50mg |
50mg |
现货 |
1202757-89-8 |
N-(3-((5-氟-2-((4-(2-甲氧基乙氧基)苯... N-(3-((5-Fluoro-2-((4-(2-met... |
98+% |
205.00
205.00
|
|
毕得 |
BD328411-100mg |
100mg |
现货 |
1202757-89-8 |
N-(3-((5-氟-2-((4-(2-甲氧基乙氧基)苯... N-(3-((5-Fluoro-2-((4-(2-met... |
98+% |
348.00
348.00
|
|
毕得 |
BD328411-250mg |
250mg |
现货 |
1202757-89-8 |
N-(3-((5-氟-2-((4-(2-甲氧基乙氧基)苯... N-(3-((5-Fluoro-2-((4-(2-met... |
98+% |
688.00
688.00
|
|
毕得 |
BD328411-1g |
1g |
现货 |
1202757-89-8 |
N-(3-((5-氟-2-((4-(2-甲氧基乙氧基)苯... N-(3-((5-Fluoro-2-((4-(2-met... |
98+% |
1,722.00
1,722.00
|
|
Acros |
468061000 |
100MG |
现货 |
1202757-89-8 |
斯比布鲁替尼,95% Spebrutinib, 95% |
|
5,432.00
5,432.00
|
|